Abstract:Background and objective. Allergic rhinitis (AR), a highly frequently seen chronic inflammation of the upper respiratory tract, shows a growing global incidence. The modern research on the pro-inflammatory mechanism molecularly offers a new direction for the early therapy AR in the future and also reveals the potential therapeutic targets of IT, which is known as the breakthrough of diagnosis and therapy of AR. Through the screening of GSE43523 data set in GEO, we discovered aberrant expression of granzyme B (GzmB) gene in AR cases. Online data analysis revealed the possible regulation of upstream target microRNA-378a-3p (miR-378a-3p) on its expression. Accordingly, this study analysed the impacts of miR-378a-3p and GzmB on AR to set the foundation for the follow-up associated research and offer novel ideas and directions for the future diagnosis and therapy of AR. Methods. Totally, 24 BALB/c mice were assigned to the AR group, control group, GzmB group, and blank group (each n = 6). The blank group was normally fed without treatment, and the other three groups were treated by ovalbumin (OVA) to induce AR models, in which the GzmB group was intranasally injected with lentiviral vector suppressing GzmB expression during the second immunization, while the control group was given the GzmB-blank vector. The times of AR pathological behaviours such as sneezing and scratching the nose of mice were observed and counted. The nasal lavage fluid of each mouse was acquired, and then, the mouse was executed by cervical dislocation, followed by collection of blood and nasal mucosa tissues. Then, ELISA was adopted for quantifying immunoglobulin E (IgE), interleukin (IL)-4, IL-6, and histamine (HA), and nasal mucosa tissues were treated by HE and TUNEL staining to observing their histopathological manifestations. PCR and western blot (WB) were adopted for quantifying GzmB and miR-378a-3p. Additionally, with NP69 cells, dual luciferase reporter (DLR) assay was carried out for determining the targeting association of GzmB with miR-378a-3p. Another 24 mice were assigned to the AR group, GzmB group, miR-378a-3p group, and GzmB+ miR-378a-3p group (each n = 6). The AR and GzmB groups were treated as above. The miR-378a-3p group was intervened by lentiviral vector suppressing miR-378a-3p, while the GzmB+ miR-378a-3p group was given GzmB and lentiviral vector suppressing miR-378a-3p meantime. A rescue assay was conducted through repeating the above tests. Results. The times of sneezing and rubbing the nose and the levels of IgE, IL-4, IL-6, and HA were similar between the control and AR groups (all P > 0.05 ), and these items of the two groups were all higher than those of the blank and GzmB groups (all P < 0.05 ). However, no notable difference was observed in IL-4 and IL-6 levels between the GzmB and blank groups (both P > 0.05 ), while higher levels of other detection results were found in the former group than in the latter (all P < 0.05 ). The staining results revealed obvious congestion, oedema, and necrosis structures in the nasal mucosa epithelium of the control and AR groups and also revealed a large number of infiltrating eosinophils and notable increase of apoptotic nasal mucosa epithelial cells. The GzmB group showed notably improved nasal mucosa tissues, and its infiltration and apoptosis of eosinophils were more notable than those of the blank group, but notably weaker than those of the AR and control groups. Additionally, the PCR and WB results revealed similar miR-378a-3p and GzmB levels in nasal mucosa between the control and AR groups (both P > 0.05 ), and a notable decrease of miR-378a-3p and a notable increase of GzmB in both groups (both P < 0.05 ). The DLR assay revealed notably suppressed fluorescence activity of GzmB-WT in NP69 cells after transfection of miR-378a-3p mimics ( P < 0.05 ) and notably down regulated GzmB pro -Abstract Truncated-

Increased Mir-124-3p Alleviates Type 2 Inflammatory Response in Allergic Rhinitis Via IL-4Rα

miR-124-3p relieves allergic rhinitis by inhibiting dipeptidyl peptidase-4

miR-224-5p Attenuates Allergic Responses in Mice with Allergic Rhinitis by Modulating the Th1/Th2 Response

CircRNA Expression Profiles and Circrna-Mirna-mrna Crosstalk in Allergic Rhinitis

MiR-150-5p regulates the functions of type 2 innate lymphoid cells via the ICAM-1/p38 MAPK axis in allergic rhinitis

MicroRNA-345-5p acts as an anti-inflammatory regulator in experimental allergic rhinitis via the TLR4/NF-κB pathway

MiR-193b-3p Regulates TLR4 Expression to Inhibit Inflammation by Targeting ETS1 in Allergic Rhinitis.

Overexpression of miR-224-5p alleviates allergic rhinitis in mice via the TLR4/MyD88/NF-κB pathway

MiR-224 Ameliorates Inflammation and Symptoms in Mouse Model of Allergic Rhinitis by Targeting CDK9

Regulatory Effect of Microrna-135A on the Th1/Th2 Imbalance in a Murine Model of Allergic Rhinitis.

MicroRNA-29 Mediates Anti-Inflammatory Effects and Alleviation of Allergic Responses and Symptoms in Mice with Allergic Rhinitis

Antagonism of m3 Alleviates Type 2 Inflammation in Allergic Rhinitis Mice.

miR-31 attenuates murine allergic rhinitis by suppressing interleukin-13-induced nasal epithelial inflammatory responses

Influences of miR-378a-3p on the Pathogenesis of Allergic Rhinitis via GzmB-Mediated Inflammatory Reaction

Mir-143 Inhibits Interleukin-13-induced Inflammatory Cytokine and Mucus Production in Nasal Epithelial Cells from Allergic Rhinitis Patients by Targeting IL13Rα1

Knockdown of miR‐205‐5p alleviates the inflammatory response in allergic rhinitis by targeting B‐cell lymphoma 6

Microarray analysis of differentially expressed microRNAs in allergic rhinitis.

Increased Expression Of Mir-146a In Children With Allergic Rhinitis After Allergen-Specific Immunotherapy

Micro124-mediated AHR Expression Regulates the Inflammatory Response of Chronic Rhinosinusitis (CRS) with Nasal Polyps

Intranasal Administration of Lentiviral miR-135a Regulates Mast Cell and Allergen-Induced Inflammation by Targeting GATA-3

Effects of anticholinergic agent on miRNA profiles and transcriptomes in a murine model of allergic rhinitis.